Joris H. De Maeyer

958 total citations
24 papers, 787 citations indexed

About

Joris H. De Maeyer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joris H. De Maeyer has authored 24 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joris H. De Maeyer's work include Gastrointestinal motility and disorders (6 papers), Phosphodiesterase function and regulation (6 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Joris H. De Maeyer is often cited by papers focused on Gastrointestinal motility and disorders (6 papers), Phosphodiesterase function and regulation (6 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Joris H. De Maeyer collaborates with scholars based in Belgium, Netherlands and Czechia. Joris H. De Maeyer's co-authors include J. A. J. Schuurkes, Romain A. Lefebvre, Vincenzo Stanghellini, Lin Chang, James J. Galligan, S. Müller‐Lissner, Eamonn M.M. Quigley, Jan Tack, Brian E. Lacy and William D. Chey and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Infectious Diseases.

In The Last Decade

Joris H. De Maeyer

24 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joris H. De Maeyer Belgium	13	440	282	159	145	129	24	787
Klaas Prins Belgium	15	505 1.1×	277 1.0×	168 1.1×	171 1.2×	164 1.3×	25	804
J.A.J. Schuurkes Belgium	11	306 0.7×	204 0.7×	128 0.8×	123 0.8×	125 1.0×	14	565
Takeshi Kamato Japan	18	273 0.6×	349 1.2×	261 1.6×	191 1.3×	232 1.8×	43	878
Narcisa Ghisu Italy	17	174 0.4×	136 0.5×	153 1.0×	108 0.7×	77 0.6×	26	828
Kenjiro Matsumoto Japan	18	252 0.6×	160 0.6×	197 1.2×	188 1.3×	125 1.0×	38	830
H.D. Allescher Germany	17	207 0.5×	156 0.6×	137 0.9×	155 1.1×	162 1.3×	39	708
John Broad United Kingdom	14	277 0.6×	134 0.5×	78 0.5×	188 1.3×	72 0.6×	23	546
Leonard S. Dove United States	12	502 1.1×	266 0.9×	217 1.4×	174 1.2×	219 1.7×	22	809
R Takayanagi Japan	11	285 0.6×	116 0.4×	96 0.6×	187 1.3×	117 0.9×	22	614
Ian Spreadbury Canada	12	263 0.6×	106 0.4×	210 1.3×	222 1.5×	84 0.7×	17	777

Countries citing papers authored by Joris H. De Maeyer

Since Specialization

Citations

This map shows the geographic impact of Joris H. De Maeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joris H. De Maeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joris H. De Maeyer more than expected).

Fields of papers citing papers by Joris H. De Maeyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joris H. De Maeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joris H. De Maeyer. The network helps show where Joris H. De Maeyer may publish in the future.

Co-authorship network of co-authors of Joris H. De Maeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Joris H. De Maeyer. A scholar is included among the top collaborators of Joris H. De Maeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joris H. De Maeyer. Joris H. De Maeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doll, Robert J., Nicoline Voet, Wessel Kraaij, et al.. (2023). Smartphone and Wearable Sensors for the Estimation of Facioscapulohumeral Muscular Dystrophy Disease Severity: Cross-sectional Study. JMIR Formative Research. 7. e41178–e41178. 4 indexed citations

Doll, Robert J., Nicoline Voet, Adam F. Cohen, et al.. (2022). Objective Monitoring of Facioscapulohumeral Dystrophy During Clinical Trials Using a Smartphone App and Wearables: Observational Study. JMIR Formative Research. 6(9). e31775–e31775. 8 indexed citations

Bijvelds, Marcel J. C., Gary Tresadern, Karine Smans, et al.. (2018). Selective inhibition of intestinal guanosine 3′,5′-cyclic monophosphate signaling by small-molecule protein kinase inhibitors. Journal of Biological Chemistry. 293(21). 8173–8181. 8 indexed citations

Conlon, Kelly, Joris H. De Maeyer, C. Bruce, et al.. (2017). Nonclinical Cardiovascular Studies of Prucalopride, a Highly Selective 5-Hydroxytryptamine 4 Receptor Agonist. Journal of Pharmacology and Experimental Therapeutics. 364(2). 156–169. 9 indexed citations

Lefebvre, Romain A., et al.. (2016). Synergistic effect between 5-HT4 receptor agonist and phosphodiesterase 4-inhibitor in releasing acetylcholine in pig gastric circular muscle in vitro. European Journal of Pharmacology. 781. 76–82. 7 indexed citations

Bijvelds, Marcel J. C., Inez Bronsveld, Luc Ver Donck, et al.. (2015). Inhibition of Heat-Stable Toxin–Induced Intestinal Salt and Water Secretion by a Novel Class of Guanylyl Cyclase C Inhibitors. The Journal of Infectious Diseases. 212(11). 1806–1815. 20 indexed citations

Lo, Adrian C., Joris H. De Maeyer, Ben Vermaercke, et al.. (2014). SSP-002392, a new 5-HT4 receptor agonist, dose-dependently reverses scopolamine-induced learning and memory impairments in C57Bl/6 mice. Neuropharmacology. 85. 178–189. 32 indexed citations

Tesseur, Ina, Anna A. Pimenova, Adrian C. Lo, et al.. (2013). Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice. Neurobiology of Aging. 34(7). 1779–1789. 46 indexed citations

Maeyer, Joris H. De, et al.. (2013). Influence of phosphodiesterases on basal and 5-HT4 receptor facilitated cholinergic contractility in pig descending colon. European Journal of Pharmacology. 705(1-3). 156–163. 7 indexed citations

10.

Windhorst, Albert D., Marc C. Huisman, Joris H. De Maeyer, et al.. (2013). Radiosynthesis and preclinical evaluation of [11C]prucalopride as a potential agonist PET ligand for the 5-HT4 receptor. EJNMMI Research. 3(1). 24–24. 12 indexed citations

11.

Maeyer, Joris H. De, et al.. (2013). Influence of phosphodiesterases and cGMP on cAMP generation and on phosphorylation of phospholamban and troponin I by 5-HT4 receptor activation in porcine left atrium. Naunyn-Schmiedeberg s Archives of Pharmacology. 386(8). 671–684. 8 indexed citations

12.

Dupont, Lieven, Ken R. Bracke, Joris H. De Maeyer, et al.. (2013). Investigation of 5-HT4 receptors in bronchial hyperresponsiveness in cigarette smoke-exposed mice. Pulmonary Pharmacology & Therapeutics. 28(1). 60–67. 9 indexed citations

13.

Maeyer, Joris H. De, et al.. (2012). Study of the regulation of the inotropic response to 5-HT4 receptor activation via phosphodiesterases and its cross-talk with C-type natriuretic peptide in porcine left atrium. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(6). 565–577. 13 indexed citations

14.

Tack, Jan, Michael Camilleri, Lin Chang, et al.. (2012). Systematic review: cardiovascular safety profile of 5‐HT₄agonists developed forgastrointestinaldisorders. Alimentary Pharmacology & Therapeutics. 35(7). 745–767. 214 indexed citations

15.

Chai, Wenxia, Kayi Y. Chan, René de Vries, et al.. (2012). Inotropic effects of prokinetic agents with 5-HT4 receptor agonist actions on human isolated myocardial trabeculae. Life Sciences. 90(13-14). 538–544. 11 indexed citations

16.

Maeyer, Joris H. De, et al.. (2011). The facilitating effect of prucalopride on cholinergic neurotransmission in pig gastric circular muscle is regulated by phosphodiesterase 4. Neuropharmacology. 62(5-6). 2126–2135. 22 indexed citations

17.

Maeyer, Joris H. De, et al.. (2011). In-vitro acetylcholine release is not a straightforward model to study hippocampal 5-HT4 receptors. Neuroreport. 22(17). 892–896. 3 indexed citations

18.

Maeyer, Joris H. De, J.A.J. Schuurkes, & R A Lefebvre. (2009). Selective desensitization of the 5‐HT₄receptor‐mediated response in pig atrium but not in stomach. British Journal of Pharmacology. 156(2). 362–376. 25 indexed citations

19.

Maeyer, Joris H. De, Romain A. Lefebvre, & J. A. J. Schuurkes. (2008). 5‐HT₄receptor agonists: similar but not the same. Neurogastroenterology & Motility. 20(2). 99–112. 200 indexed citations

20.

Maeyer, Joris H. De, Klaas Prins, J. A. J. Schuurkes, & Romain A. Lefebvre. (2006). Differential Effects of 5-Hydroxytryptamine4 Receptor Agonists at Gastric versus Cardiac Receptors: An Operational Framework to Explain and Quantify Organ-Specific Behavior. Journal of Pharmacology and Experimental Therapeutics. 317(3). 955–964. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact